Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The landscape of 8q24 cytoband in gastric cancer (Review). | Oncol Lett | 2024 | 38464340 | PubTator, text mining | PubMed |
| VDR, CXCR1, CXCR2, PSCA Polymorphisms and Recurrent Urinary Tract Infections in Women: Genetic Association Study. | Int Urogynecol J | 2024 | 38407596 | PubTator, text mining | PubMed |
| Graphene Oxide Nanoparticles and Organoids: A Prospective Advanced Model for Pancreatic Cancer Research. | Int J Mol Sci | 2024 | 38256139 | PubTator, text mining | PubMed |
| Preoperative Factors for Lymphovascular Invasion in Prostate Cancer: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2024 | 38255928 | PubTator, text mining | PubMed |
| A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. | Cancers (Basel) | 2024 | 38254823 | PubTator, text mining | PubMed |
| Breakthrough of solid tumor treatment: CAR-NK immunotherapy. | Cell Death Discov | 2024 | 38245520 | PubTator, text mining | PubMed |
| Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. | J Exp Clin Cancer Res | 2024 | 38167055 | PubTator, text mining | PubMed |
| Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy. | J Cancer | 2024 | 38164273 | PubTator, text mining | PubMed |
| Expanded Alternatives of CRISPR-Cas9 Applications in Immunotherapy of Colorectal Cancer. | Mol Diagn Ther | 2024 | 37907826 | PubTator, text mining | PubMed |
| Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. | Transl Oncol | 2024 | 37897831 | PubTator, text mining | PubMed |
| Functional Annotation and Gene Set Analysis of Gastric Cancer Risk Loci in a Korean Population. | Cancer Res Treat | 2024 | 37340842 | PubTator, text mining | PubMed |
| Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response. | Curr Oncol | 2023 | 38275827 | PubTator, text mining | PubMed |
| Mechanistic analysis of Th2-type inflammatory factors in asthma. | J Thorac Dis | 2023 | 38249931 | PubTator, text mining | PubMed |
| Advances of cell therapy in lung cancer: a narrative review. | J Thorac Dis | 2023 | 38249856 | PubTator, text mining | PubMed |
| Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility. | Int J Mol Sci | 2023 | 38203561 | PubTator, text mining | PubMed |
| Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures. | Cancers (Basel) | 2023 | 38201467 | PubTator, text mining | PubMed |
| Breakthroughs in Cancer Immunotherapy: An Overview of T Cell, NK Cell, Mφ, and DC-Based Treatments. | Int J Mol Sci | 2023 | 38139461 | PubTator, text mining | PubMed |
| Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA). | Int J Mol Sci | 2023 | 38139219 | PubTator, text mining | PubMed |
| ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers. | J Clin Invest | 2023 | 38099497 | PubTator, text mining | PubMed |
| Symphony in the crowd: Key genetic alterations in prostate cancer. | Cancer Innov | 2023 | 38089408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=5